Didier Delanoye

Didier has over 24 years of external audit experience working with mainly European and US multinationals, with a focus on Biotech, Pharma and Medical Device companies. He has significant experience in shared audit comfort models and using data auditing techniques.

Didier provides accounting and financial advice related to capital market transactions, mergers & acquisitions, option plans, (re)structuring and group reorganisations. He has significant experience in auditing and advising on internal control matters (including Sarbanes-Oxley) and implementing shared service centres.

He completed a two-year secondment to the UK in June 2012, working mainly with a large pharmaceutical company and supporting PwC in undertaking its Audit Transformation program.

Didier is responsible for managing PwC partnerships with Pharma & Life Science organisations such as flanders.bio, BioWin, Pharma.be, and Medvia.

He is fluent in Dutch, English and French and has basic knowledge of German.